Heraeus: PALACOS Available Direct in U.S.

Hanau, Germany-based Heraeus Medical, inventor and manufacturer of PALACOS bone cement products, is announcing that is has begun selling these products direct in the U.S. through its affiliate Heraeus Medical LLC.

“The company is extremely excited about the opportunity to support total joint surgeons directly in the U.S. in providing consistent, predictable outcomes with the potential for lower revision rates,” said Dr. Andrew Williamson, Heraeus Medical board member, in the January 15, 2018 news release. Devin Childers, vice president and general manager of Heraeus Medical LLC, added, “The expertise and knowledge Heraeus Medical can directly offer its loyal PALACOS users in the U.S. creates an atmosphere of both continued innovation and collaboration.”

Dr. Williamson told OTW, “In an era of value-based care, we are most excited to collaborate with physicians and health systems on improving outcomes in joint replacement surgery. Internationally, Heraeus is a leader in joint fixation and periprosthetic infection management. Over the course of 2018, we are excited to introduce new products and our Palacademy education platforms to the U.S. market that enable the pursuit of value-based care. We also hope to engage in better and creative relationships with health systems and work with them on research that advances the care of orthopedic patients.”